Form D · Biotechnology
OCULAR THERAPEUTIX, INC
Bedford, MA · CIK 0001393434
Offering snapshot reported Mar 18, 2019 · SEC filing
- Reported sold
- $37.5M Offering amount: $37.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 1, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 18, 2019 | Initial | $37,500,000 | No comparison | 1 | SEC filing |
| Jun 10, 2013 | Initial | $8,500,002 | No comparison | 2 | SEC filing |
| Feb 8, 2011 | Initial | $14,000,001 | No comparison | 9 | SEC filing |
| Jan 12, 2011 | Amendment | $21,000,000 | $6,000,000vs Jul 2, 2009 | 29 | SEC filing |
| Jul 2, 2009 | Initial | $15,000,000 | No comparison | 16 | SEC filing |
| Jul 1, 2009 | Amendment | $1,145,836 | No comparison | 18 | SEC filing |
| Jul 1, 2009 | Initial | $6,000,000 | No comparison | 13 | SEC filing |
| Mar 6, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $75K (estimated)
- Form D file number
- 021-335084
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Piper Jaffray & Co. | 665 |
Source: Form D, filed Mar 18, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Bollag | Executive |
| Steven Cagnetta | Executive |
| Jaswinder Chadha | Director |
| Alan Crain | Director |
| Alan Crane | Director, Executive |
| James Garvey | Director, Executive |
| Michael Goldstein | Executive |
| Bernard Haffey | Director, Executive |
| Kevin Hanley | Executive |
| Jeffrey S. Heier | Director |
| Farhad Khosravi | Director, Executive |
| Brian Levy | Director |
| Richard L. Lindstrom | Director |
| Antony Mattessich | Director, Executive |
| Daniel Myers | Director, Executive |
| Donald Notman | Executive |
| W. James O'shea | Director |
| Bruce A. Peacock | Director |
| Amarpreet Sawhney | Director |
| Charles Warden | Director |
| Samuel Wu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
15 Crosby Drive
Bedford, MA, 01730
Bedford, MA, 01730